Recovery from (treatment-resistant) depression after lifestyle changes and micronutrient precision supplementation: a preliminary field study in patients.
Cost containment
Depression
Laboratory tests
Nutrition
Precision nutrition
Journal
BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676
Informations de publication
Date de publication:
11 Aug 2023
11 Aug 2023
Historique:
received:
13
11
2022
accepted:
26
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
11
8
2023
Statut:
epublish
Résumé
The incidence of depression is increasing, despite continued advances in psychological and pharmacological interventions. New treatment approaches are urgently needed. Here we assess the effects on depression of individualized micronutrient supplementation, in concert with a standard set of lifestyle changes. We conducted a small field-study with 17 participants in Austria. Patients with depression (n = 11) and healthy volunteers (n = 6) underwent laboratory serum analysis and filled out the DASS-21 and a questionnaire about their medical history and condition. The list of parameters to be tested in the serum analysis was derived from an expert heuristic compilation of factors known to influence depression, narrowed down to a workable list to be tested in this initial study. On the basis of the results, the participants (n = 17) received individualized recommendations for micronutrient supplementation, in collaboration with their treating physician. Participants followed the individual supplementation regime for two months, along with a standard set of lifestyle changes. After two months the laboratory serum analyses, the DASS-21, and the questionnaire were repeated. All patients with micronutrient deficiencies were in the patient group; none of the healthy volunteers showed any micronutrient deficiencies. After two months of precision supplementation and lifestyle changes, all but one patient had recovered from their depression or had considerably improved. The one patient who didn't recover was the only one with a known trigger of their depression (trauma). Of 11 patients with depression, the trigger was unknown for the other ten. These results have promising implications for further research, treatment, drug development, and public health. We propose that systematic screening of patients with symptoms of depression be developed for future research, medical care, and practice. Psychiatry and psychotherapy may see improved results once they no longer have to push against the underlying constraints of existing micronutrient deficiencies.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
The incidence of depression is increasing, despite continued advances in psychological and pharmacological interventions. New treatment approaches are urgently needed. Here we assess the effects on depression of individualized micronutrient supplementation, in concert with a standard set of lifestyle changes.
METHODS
METHODS
We conducted a small field-study with 17 participants in Austria. Patients with depression (n = 11) and healthy volunteers (n = 6) underwent laboratory serum analysis and filled out the DASS-21 and a questionnaire about their medical history and condition. The list of parameters to be tested in the serum analysis was derived from an expert heuristic compilation of factors known to influence depression, narrowed down to a workable list to be tested in this initial study. On the basis of the results, the participants (n = 17) received individualized recommendations for micronutrient supplementation, in collaboration with their treating physician. Participants followed the individual supplementation regime for two months, along with a standard set of lifestyle changes. After two months the laboratory serum analyses, the DASS-21, and the questionnaire were repeated.
RESULTS
RESULTS
All patients with micronutrient deficiencies were in the patient group; none of the healthy volunteers showed any micronutrient deficiencies. After two months of precision supplementation and lifestyle changes, all but one patient had recovered from their depression or had considerably improved. The one patient who didn't recover was the only one with a known trigger of their depression (trauma). Of 11 patients with depression, the trigger was unknown for the other ten.
CONCLUSIONS
CONCLUSIONS
These results have promising implications for further research, treatment, drug development, and public health. We propose that systematic screening of patients with symptoms of depression be developed for future research, medical care, and practice. Psychiatry and psychotherapy may see improved results once they no longer have to push against the underlying constraints of existing micronutrient deficiencies.
Identifiants
pubmed: 37568156
doi: 10.1186/s40359-023-01263-7
pii: 10.1186/s40359-023-01263-7
pmc: PMC10422823
doi:
Substances chimiques
Micronutrients
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
229Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Nutrients. 2021 Sep 27;13(10):
pubmed: 34684391
Neurosci Biobehav Rev. 2019 Dec;107:525-539
pubmed: 31586447
Cell. 2018 May 17;173(5):1265-1279.e19
pubmed: 29775595
Sci Rep. 2019 Dec 23;9(1):19720
pubmed: 31873098
Physiol Rep. 2019 Aug;7(16):e14213
pubmed: 31444870
Curr Med Chem. 2021;28(35):7295-7311
pubmed: 33200694
Lancet Reg Health Am. 2021 Sep;1:100009
pubmed: 34514462
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Clin Exp Optom. 2019 Mar;102(2):99-108
pubmed: 30074278
Am Fam Physician. 2017 Sep 15;96(6):384-389
pubmed: 28925645
J Psychosoc Nurs Ment Health Serv. 2017 Jul 1;55(7):7-11
pubmed: 28671236
J Affect Disord. 2017 Jan 15;208:56-61
pubmed: 27750060
Nat Rev Dis Primers. 2017 Jun 29;3:17040
pubmed: 28660890
Transl Psychiatry. 2018 Nov 5;8(1):242
pubmed: 30397195
Cell Host Microbe. 2018 Jun 13;23(6):716-724
pubmed: 29902437
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
Eur J Clin Nutr. 2020 Nov;74(11):1498-1513
pubmed: 31959942
J Neurosci Res. 2020 Apr;98(4):588-600
pubmed: 30051488
Pharmacol Ther. 2019 Sep;201:51-76
pubmed: 31051197
Scand J Med Sci Sports. 2014 Apr;24(2):259-72
pubmed: 23362828
J Psychiatr Res. 2017 Dec;95:9-18
pubmed: 28759846
F1000Res. 2020 Jan 31;9:
pubmed: 32051759
Maturitas. 2017 Feb;96:58-71
pubmed: 28041597
Front Neurosci. 2020 Dec 07;14:582853
pubmed: 33364919
Neuroscience. 2015 Sep 24;304:90-100
pubmed: 26210580
Nutrients. 2017 Jun 27;9(7):
pubmed: 28654017
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Clin Chem Lab Med. 2017 Aug 28;55(9):1262-1275
pubmed: 27988504
Psychoneuroendocrinology. 2019 Mar;101:138-149
pubmed: 30458371
Int J Mol Sci. 2020 Dec 07;21(23):
pubmed: 33297303
Aging Clin Exp Res. 2021 Jan;33(1):19-24
pubmed: 32857334
Arch Biochem Biophys. 2014 Mar 15;546:1-7
pubmed: 24407024
Transl Psychiatry. 2017 Jan 31;7(1):e1017
pubmed: 28140399
Nature. 2018 Jul;559(7712):38-40
pubmed: 29959409
Curr Med Chem. 2016;23(38):4317-4337
pubmed: 27655070
FASEB J. 2015 Jun;29(6):2207-22
pubmed: 25713056
BMC Psychiatry. 2020 Feb 13;20(1):63
pubmed: 32054533
Cureus. 2021 Sep 20;13(9):e18138
pubmed: 34692346
Front Neurosci. 2021 May 13;15:670879
pubmed: 34054418
Front Neuroendocrinol. 2019 Jul;54:100746
pubmed: 31002895
BMC Psychiatry. 2020 Jun 18;20(1):315
pubmed: 32552785
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Transl Psychiatry. 2019 Aug 5;9(1):190
pubmed: 31383846
Aust N Z J Psychiatry. 2008 Mar;42(3):192-8
pubmed: 18247193
Schmerz. 2015 Dec;29(6):649-57
pubmed: 26205682
J Genet Couns. 2016 Oct;25(5):901-11
pubmed: 27130656
BMJ. 2014 Sep 04;349:g5226
pubmed: 25189324